Sara Bleve

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Emanuela Scarpi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

giuseppe schepisi

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

Emilio Francesco Giunta

Università degli Studi della Campania Luigi Vanvitelli

ITALY

View details

GIOVANNI MARTINELLI

Associated Professor

University of Bologna

ITALY

View details

Marco Stellato

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Vincenza Conteduca

Associate Professor

University of Foggia

ITALY

View details

Nicole Brighi

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sara Bleve

Research Interests

Explore related searches

Contact this professor

Articles (10)

An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.

Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer

Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors.

Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer.

Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial.

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer.

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.

Collaborators (7)

Emanuela Scarpi

giuseppe schepisi

Emilio Francesco Giunta

GIOVANNI MARTINELLI

Marco Stellato

Vincenza Conteduca

Nicole Brighi

Make your next move.